Inflammatory diseases don't boost clotting risks post-COVID, study reveals

Canadian researchers found that patients with immune-mediated inflammatory diseases (IMIDs) don't face a heightened risk of venous thromboembolism events after recovering from COVID-19 compared to those without IMIDs. However, certain comorbidities can influence this risk, emphasizing the importance of individualized patient care.

Related Keywords

Canada ,Kateryna Kon , ,Venous Thromboembolism After ,Among People With ,Without Immune Mediated Inflammatory ,Image Credit ,Charlson Comorbidity Index ,Coronavirus Disease Covid 19 ,Arthritis ,Hronic ,Coronavirus ,Covid 19 ,Deep Vein Thrombosis ,Immune System ,Inflammation ,Inflammatory Bowel Disease ,Multiple Sclerosis ,Psoriasis ,Espiratory ,Rheumatoid Arthritis ,Cars ,Ars Cov 2 ,Clerosis ,Evere Acute Respiratory ,Evere Acute Respiratory Syndrome ,Yndrome ,Thromboembolism ,Hrombosis ,Vasculitis ,Venous Thromboembolism ,